U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The production of too many useful things results in too many useless people."

Karl Marx

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 549/305 - Chalcogen attached indirectly to the lactone ring by acyclic nonionic bonding


Subclass of Class 549 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein chalcogen (i.e., oxygen, sulfur, selenium,
No. of patents: 136
Last issue date: 09/01/2009


1        
NumberTitleIssue Date
7582779Processes and intermediates for the preparations of prostaglandins
The present invention provides novel processes for the preparation of a cyclopentanone of Formula II and a lactone of Formula I, which are useful in the production of prostaglandins: wherein Z, R2, R3,...
09/01/2009
7439373Crystalline mycophenolate sodium
Provided are crystalline mycophenolate sodium forms and processes for their preparation. ...
10/21/2008
7282596Method and intermediate for preparing a prostaglandin F-type compound
A method for preparing a prostaglandin F-type compound. Also disclosed is an intermediate of the following formula (II) compound wherein R′, X and A have the same meaning as given in the specification. ...
10/16/2007
7276533Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
This invention features the use of the spirolaxine of formula (I) for the treatment of those pathologies responding to the activation of the PPARγ receptor, such as the Type 2 insulin-resistant diabetes. This invention also features a pharmaceutical composition in ...
10/02/2007
7271273Method for the preparation of citalopram
The invention provides a new and improved method for the preparation of 5-cyano-phtalid, which is a key intermediate in the preparation of the antidepressant compound citalopram. ...
09/18/2007
7268239Process for the preparation of prostaglandins and analogues thereof
Disclosed are processes for the synthesis and purification of prostaglandins and analogues thereof, especially analogues of PGF2α. ...
09/11/2007
RE397553-(1-hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one a process for the preparation thereof and the use thereof
A product corresponding to formula (I) or its ketonic tautomer form (II) which is 3-(1-hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one, a process for the preparation and use of the product corresponding to formula (I) or its tau...
07/31/2007
7145020Materials and methods for treating coagulation disorders
This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches met...
12/05/2006
7122687Process for the production of an immunosuppressant
In one aspect, the present invention provides a process for producing a sodium salt of an immunosupressant of Formula I ...
10/17/2006
7109371Prostaglandin synthesis
A process for the preparation of prostaglandin compounds having the formula (I): wherein A is selected from the group consisting of C1–C6 alkyl groups; C7–C16 aralk...
09/19/2006
7026351Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
The present invention provides cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, methods of making cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs and compositions of cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs. The present invention also provides methods o...
04/11/2006
6992197Lactone compound
A novel monomer compound having a lactone moiety of the present invention can be converted into polymers usable as resist materials with excellent properties, etc., and an alcohol compound having a lactone moiety of the invention is useful as a material for the mono...
01/31/2006
6911548Method for the preparation of 5-cyanophthalide
A method for the preparation of 5-cyanophthalide comprising treatment of a compound of formula IV wherein X is O or S; R1-R2 are each independently selected from...
06/28/2005
6888009Method for the preparation of 5-carboxyphthalide
5-carboxyphthalide is obtained with very high purity and in high yields by a convenient process comprising reaction of terephthalic acid with paraformaldehyde HO(CH2)nH in oleum. ...
05/03/2005
6868215Dye thin film, production method thereof, optical switch, optical distributor, optical modulator and optical switch array
A dye thin film containing a dye compound represented by the general formula (I), an optical switch, an optical distributor, an optical modulator and an optical switch array having the dye thin film, as well as a method for producing a dye thin film are provided. Th...
03/15/2005
6864279Materials and methods for treating coagulation disorders
This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches met...
03/08/2005
6825363Compounds useful in optical switching and manufacturing method thereof
A dibenzofuranonylium methylate compound represented by the following formula (I), having maximum absorption wavelength of over 1 μm, high thermal stability and good solubility in organic solvents, and a production method thereof are provided:
11/30/2004
68092083-Arylbenzofuranones with electron-withdrawing substituents as stabilizers
The invention describes novel compounds of the formula (I) wherein the general symbols are as defined in claim (1) and R1 is an aromatic radical with electron withdrawing substituents, as stabilizers for protecting organic materials, in particular polymer...
10/26/2004
6780887Anti-ischemic compounds
The present invention is related to a compound of formula (I), salts and pro-drugs of the compound (I) and methods for treating and/or preventing partial or total ischemia, methods for treating and/or preventing pathologies associated with ischemia or with mitochond...
08/24/2004
6762327Selective oxidation process with enhanced safety
A safe and effective process for the oxidation of a primary or secondary alcohol to the corresponding aldehyde or ketone via the reaction of said alcohol with an anhydride solution of a 1,1,1-tri(C2-C4 alkanoyloxy-1,1-dihydro-1,2-benziodoxol-3(...
07/13/2004
6703516Process for the preparation of 5-carboxyphthalide
There is described a process for the preparation of 5-carboxy phthalide, which comprises adding terephthalic acid to fuming sulfuric acid containing at least 20% of SO3, then adding formaldehyde to the mixture, heating the mixture at a temperat...
03/09/2004
6586606Process for the preparation of 3-aryl-benzofuran-2-ones
The instant invention discloses a process for the preparation of compounds of formula I ##STR1## wherein the general symbols are as defined in claim 1, which process comprises hydrolyzing a compound of formula V ##STR2## wherein the general symbols a...
07/01/2003
65151473-(1-hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one a process for the preparation thereof and the use thereof
A product corresponding to formula (I) or its ketonic tautomer form (II) ##STR1## which is 3-(1-hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one, a process for the preparation and use of the product corresponding to formula (I) or its tautomeric form (II)...
02/04/2003
6500962Production method of ଱-methylene-γ-butyrolactones
The present invention relates to a method for producing an ଱-methylene-γ-butyrolactone which is one of basic structures often shown in drugs such as an anti-cancer agent by reacting an alene compound having an aldehyde or ketone group with carbon m...
12/31/2002
6482959Process for the stereoselective reduction of ଱,ଲ-unsaturated ketones
A process for the preparation of ଱,ଲ-unsaturated alcohols of general formula (I), ##STR1## wherein R means an alkyl group of 1-4 carbon atoms, or benzoyloxy group optionally substituted with a phenyl group; R1 means a hydrogen atom ...
11/19/2002
6462074Substituted ଱, ଲ-anellated butyrolactones
The present invention relates to novel substituted (଱,ଲ-fused butyrolactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in...
10/08/2002
6458973Process for the preparation of 5-carboxyphthalide
There is described a process for the preparation of 5-carboxy phthalide, which comprises adding terephthalic acid to fuming sulfuric acid containing at least 20% of SO3, then adding formaldehyde to the mixture, heating the mixture at a temperat...
10/01/2002
6429203Farnesyl-protein transferase inhibitors
Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described...
08/06/2002
6403813Method for the preparation of 5-carboxyphthalide
5-carboxyphthalide is obtained with very high purity and in high yields by a convenient process comprising reaction of terephthalic acid ##STR1## with paraformaldehyde HO(CH2)n H in oleum....
06/11/2002
6376539Substituted bicyclic lactones
The present invention relates to novel substituted bicyclic lactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cereb...
04/23/2002
6376535Oxygen-containing heterocyclic compounds
The present invention relates to oxygen-containing heterocyclic compounds represented by the following formula (I): ##STR1## wherein m represents an integer of 0 to 4; R1, R2, R3 and R4 independently represent a...
04/23/2002
6268394Farnesyl-protein transferase inhibitors
Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described...
07/31/2001
6207841Bisphenol derivative and its manufacturing method
A bisphenol derivative represented by the following formula and a manufacturing method thereof are disclosed. ##STR1## where R is a lower alkyl group, tetrahydropyranyl, methoxymethyl or trialkylsilyl group, and the benzene rings in the formula may be ...
03/27/2001
6153645Heterocycles as antimicrobial agents
Methods for treating infection and related compositions, compounds of formula I as defined in the application and methods for preparing same, are provided. In general, the compounds inhibit transfer ribonucleic acid (tRNA) synthetase and are useful as ant...
11/28/2000
6100292Ketone derivatives and their medical applications
This invention relates to ketones represented by the following formula ##STR1## and to drugs in which such a ketone or pharmacologically acceptable salt thereof is an effective component. The ketones of the present invention encourage the production of pl...
08/08/2000
6051565Farnesyl-protein transferase inhibitors
Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described...
04/18/2000
6048882Prophylactic and therapeutic agent for hepatic diseases
Hepatic diseases can be prevented or treated by administering an isoprenylamine derivative represented by the general formula (II) ##STR1## [wherein n represents an integer of 4-12, m represents an integer of 0-3, Ar represents a phenyl group, a fury...
04/11/2000
6028204Process for preparing phthalides
The disclosure is a process for preparing a phthalide of the general formula I ##STR1## where R1, R2, R3 and R4 are each independently of the others hydrogen, C1 -C4 -alkyl or C1
02/22/2000
6020501Process for preparing phthalides
The disclosure is a process for preparing a phthalide of the general formula I ##STR1## where R1, R2, R3 and R4 are each independently of the others hydrogen, C1 -C4 -alkyl or C1
02/01/2000
5900492Method of producing optically active cyclopropane derivatives
A method for resolving optically impure 3-oxa-2-oxobicyclo›3.1.0!hexane-1-carboxylic acid esters. A method is provided for producing a 1-alkoxycarbonyl-2-hydroxymethylcyclopropane-1-carboxylic acid.N-benzyl-଱-phenylethylamine diastereomer salt...
05/04/1999
1        
 
Sign InRegister
Username  
Password   
forgot password?